Dynamics of fertility impairment and recovery after allogeneic haematopoietic stem cell transplantation in childhood and adolescence: results from a longitudinal study
- 1 August 2014
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 141 (1) , 135-142
Abstract
Fertility impairment and recovery after haematopoietic stem cell transplantation (HSCT) have been reported in both sexes, but little is known about how they develop over time. Our aim was to describe the dynamics of fertility impairment and recovery after HSCT. We retrieved treatment and fertility data for up to 12 years of 361 paediatric patients with malignant and non-malignant diseases from seven European centres. The patients had been treated with allogeneic HSCT between 2000 and 2005. Development of fertility impairment was observed in males (123/217, 56 %) after a median time of 2.6 years (range 0.1–11.4) and in females (82/144, 57 %) after 2.3 years (range 0.1–12.0) after HSCT. Different busulfan dosages had only a slight impact on the onset of fertility impairment (busulfan ≥16 mg/kg with a median time to fertility impairment of 2.9 vs. 3.9 years after busulfan <14 mg/kg). Recovery from fertility impairment was observed in 17 participants after a median time of 4.1 years (range 1–10.6) in females (10/144, 7 %) and 2.0 years (range 1–6.3) in males (7/217, 3 %) after fertility impairment first appeared. In the light of the dynamics of fertility impairment and recovery in the HSCT patients reviewed, these patients should be counselled comprehensively regarding fertility preservation measures.Keywords
This publication has 18 references indexed in Scilit:
- Association between self‐reported questionnaire data on fertility and results of hormone analyses in women after childhood cancer: A cross‐sectional studyJournal of Obstetrics and Gynaecology Research, 2012
- Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescenceBone Marrow Transplantation, 2011
- Ovarian Failure and Reproductive Outcomes After Childhood Cancer Treatment: Results From the Childhood Cancer Survivor StudyJournal of Clinical Oncology, 2009
- Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHDBlood, 2006
- Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transitionMenopause, 2004
- Nonmalignant late effects after allogeneic stem cell transplantationBlood, 2003
- Fertility preservation and management of gonadal failure associated with lymphoma therapyCurrent Oncology Reports, 2002
- Semen analysis following allogeneic bone marrow transplantation. Additional data for evidence-based counsellingBone Marrow Transplantation, 2002
- Ovarian function after autologous bone marrow transplantation in childhood: high-dose busulfan is a major cause of ovarian failureBone Marrow Transplantation, 1998
- Patterns of gonadal dysfunction following bone marrow transplantationBone Marrow Transplantation, 1998